← back to search

Zhibo Guo

Harbin Medical University · CN
Area of research
Public Health, Environmental and Occupational Health · Molecular Biology
Research interest
Research focused on Wnt signaling pathway and microRNA, with related work in Myeloid leukemia, Cancer research, Crosstalk. Notable publications include 'Circular RNA regulatory network reveals cell–cell crosstalk in acute myeloid leukemia extramedullary infiltration', 'Histone deacetylase inhibitor chidamide regulates the Wnt/β-catenin pathway by MYCN/DKK3 in B-ALL', and 'MYCN is a novel oncogenic target in adult B‐ ALL that activates the Wnt/β‐catenin pathway by suppressing DKK 3'.
h-index
citations
175
works
9
NIH funding
primary concept
email

Recent publications

Efficacy and safety of an HDACi- and HMA-based protocol in adults with acute myeloid leukemia of intermediate- and adverse-risk categories: a retrospective study
Hematology 2023cited by 3position: firstdoi
Expression analysis, clinical significance and potential function of PLXNB2 in acute myeloid leukaemia
Molecular Biology Reports 2023cited by 1position: firstdoi
Exosomal MiR-4261 mediates calcium overload in RBCs by downregulating the expression of ATP2B4 in multiple myeloma
Frontiers in Oncology 2022cited by 5position: middledoi
Histone deacetylase inhibitor chidamide regulates the Wnt/β-catenin pathway by MYCN/DKK3 in B-ALL
Investigational New Drugs 2021cited by 40position: middledoi
A circular RNA derived from PLXNB2 as a valuable predictor of the prognosis of patients with acute myeloid leukaemia
Journal of Translational Medicine 2021cited by 21position: middledoi
Growth inhibition and suppression of the mTOR and Wnt/β‐catenin pathways in T‐acute lymphoblastic leukemia by rapamycin and <i>MYCN</i> depletion
Hematological Oncology 2020cited by 8position: middledoi
Integrating microRNA and mRNA expression in rapamycin-treated T-cell acute lymphoblastic leukemia
Pathology - Research and Practice 2019cited by 7position: middledoi
Circular RNA regulatory network reveals cell–cell crosstalk in acute myeloid leukemia extramedullary infiltration
Journal of Translational Medicine 2018cited by 62position: middledoi
<i><scp>MYCN</scp></i> is a novel oncogenic target in adult B‐<scp>ALL</scp> that activates the Wnt/β‐catenin pathway by suppressing <i><scp>DKK</scp>3</i>
Journal of Cellular and Molecular Medicine 2018cited by 28position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yinghua Li · Qingdao Agricultural University9 papers (2018–2023)Lili Sun · Ministry of Education of the People's Republic of China9 papers (2018–2023)Desheng Kong · Beijing Enterprises (China)7 papers (2018–2023)Leilei Lin · Harbin Medical University7 papers (2018–2023)Sicheng Bian · Case Western Reserve University5 papers (2021–2023)Linlin Zhao · Shenyang University of Technology5 papers (2018–2023)Shengjin Fan · Harbin Medical University4 papers (2018–2023)Yanqiu Zhao · Harbin Medical University3 papers (2018–2023)Huibo Li · Harbin Medical University3 papers (2018–2019)YuHuang Wang · University of Maryland, College Park2 papers (2021–2021)Chengfang Lv · Harbin Medical University2 papers (2018–2021)Dan Guo · Kunming University of Science and Technology2 papers (2018–2021)Xialin Zhang · Shanxi Medical University1 papers (2022–2022)Bingqi Xu · Harbin Medical University1 papers (2018–2018)Wenjia Chen · National University of Singapore1 papers (2018–2018)Jin Zhou · Zhejiang Chinese Medical University1 papers (2018–2018)Zheren Wang · University of California, Berkeley1 papers (2023–2023)Hanbing Yao · Wenzhou Medical University1 papers (2022–2022)Nianjiao Liu · Harbin Medical University1 papers (2022–2022) · 1 papers (2022–2022)